Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EV/Core EBITDA

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 12.7716.1519.1713.5429.19

What is the latest EV/Core EBITDA ratio of GLAND PHARMA ?

The latest EV/Core EBITDA ratio of GLAND PHARMA is 12.77 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202612.77
Mar202516.15
Mar202419.17
Mar202313.54
Mar202229.19

How is EV/Core EBITDA of GLAND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 12.77
-20.93
Mar2025 16.15
-15.75
Mar2024 19.17
41.58
Mar2023 13.54
-53.61
Mar2022 29.19 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Core EBITDA ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹49,071.8 Cr 3.7% 14.4% 57.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.7%

14.4%

57.3%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses